Heliopolis Radio Podcast
Healing Trauma with Psychedelic Therapy
How Jill Sitnick Rewrote Her PTSD Story with MDMA
Jill Sitnick, author of Rescuing Jill and advocate for psychedelic-assisted therapy, joins Elus Radio to share her raw, inspiring journey from trauma to transformation. Diagnosed with PTSD in her late 40s, Jill opens up about how MDMA-assisted therapy and other psychedelics helped her confront deep-rooted trauma, reclaim her identity, and find lasting peace.
What Led Jill to Psychedelic Therapy?
Jill’s healing began after years of ineffective talk therapy. Her PTSD symptoms were relentless: hypervigilance, emotional numbness, and suicidal ideation. With encouragement from her therapist—who was training in psychedelic-assisted psychotherapy—she explored research on MAPS.org and chose MDMA therapy out of desperation and hope.
“After one year and three therapeutic journeys, I no longer qualified for a PTSD diagnosis. I was no longer suicidal. I believed there was a future.”
What is MDMA and How Does It Work for PTSD?
MDMA (commonly known as ecstasy or molly) is a synthetic compound developed in the early 1900s. It calms the fight-or-flight response and creates a sense of emotional safety.
In Jill’s Words:
- No hallucinations
- Physically and emotionally grounded
- Able to verbalize trauma clearly
“MDMA is like a warm hug. It calms your body enough so you can finally talk about terrifying things.”
What Other Psychedelics Did She Try?
- Psilocybin (Magic Mushrooms): Used to process trauma visuals, such as escaping childhood abuse.
- Bufo (5-MeO-DMT): Brought her into the trauma memory as her adult self, changing her perspective.
- DMT: Experienced in a safe retreat setting; described as gentle and insightful.
Each psychedelic had a unique role in Jill’s healing. MDMA helped process fear; psilocybin offered clarity; Bufo brought Jill face-to-face with her past, allowing healing through embodiment.
What Was the Treatment Protocol Like?
Jill outlines a “40/20/40” framework:
- 40% Preparation: Multiple talk therapy sessions to build trust, clarify intentions, and emotionally prepare.
- 20% Journey Day: 5–8 hours with two guides (therapist + doctor), taking a weight-based dose of MDMA.
- 40% Integration: Journaling, support, rest, and daily life reflection—sometimes lasting months.
She emphasizes not rushing the process: “Healing is not a race. It’s a relationship with yourself.”
What About Risks or Side Effects?
Jill underscores the importance of:
- Proper screening: No schizophrenia or psychosis
- Safe setting: Trusted professionals and emotional safety
- Post-care: Supplements, time off, and integration work
“Set and setting matter. This isn’t party culture. It’s serious healing work.”
Key Insights
- MDMA therapy helped Jill move from survival to stability.
- Each psychedelic offers a different “lens” on trauma.
- Integration is just as important as the journey itself.
- Set, setting, and support determine outcomes.
- Healing can be both structured and spiritual.
Frequently Asked Questions
Q: Is MDMA the same as recreational ecstasy?
A: No. Jill used medical-grade MDMA, not street substances. Purity and dosage are crucial.
Q: How long between journeys?
A: 3–6 months. Integration takes time.
Q: Can anyone try this therapy?
A: Not everyone is eligible. Screening out schizophrenia or bipolar disorder is essential.
Q: Where can I learn more?
A: Visit maps.org or Jill’s site, thejourneysage.com
.
